Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages
Clinical Diabetes · 01.07.2023 · 41 (3) · 467-473
DOI: 10.2337/cd23-0023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Diabetes, online erschienen am 07.04.2023. Verfasst von Heather P Whitley und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Auburn University Harrison College of Pharmacy, Auburn, AL. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacy Practice, Auburn University Harrison College of Pharmacy, Auburn, AL.
- Clinical Pharmacy Specialist, Baptist Family Medicine, Baptist Health System, Montgomery, AL.
- Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO.
- Department of Pharmacotherapy, Washington State University, Spokane, WA.
ORCID-Profile: Heather P Whitley, Joshua J Neumiller
Zitieren
APA
Whitley, H. P., Trujillo, J. M., & Neumiller, J. J. (2023). Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes, 41(3), 467-473. https://doi.org/10.2337/cd23-0023
Vancouver
Whitley HP, Trujillo JM, Neumiller JJ. Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes. 2023;41(3):467-473. doi:10.2337/cd23-0023
BibTeX
@article{Whitley2023,
author = {Whitley, Heather P and Trujillo, Jennifer M and Neumiller, Joshua J},
title = {Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages},
journal = {Clinical Diabetes},
year = {2023},
volume = {41},
number = {3},
pages = {467--473},
doi = {10.2337/cd23-0023}
}
EUVIMED